Myc–Max association is needed to maintain both normal and tumor cell proliferation and inhibiting this for therapeutic purposes in cancer, whether by pharmacologic or genetic means, has been a long-desired goal [6,7,8,50,153,154,155,156,157,158]. The gene discussed is MYC; the disease is neoplasm.